Search

everythinglearnresearchcommunity

for

Search:↓

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Obese women with PCOS are more likely to have fatty liver disease.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Bald men may have higher heart disease risk.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Genetic marker rs12558842 strongly linked to male hair loss.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.